Aurobindo Pharma hit a 52-week high of Rs 405 on good results before closing at Rs 396.55, up 6.37 per cent from its previous close.
More than 93,190 shares of the company were traded. For Q4 ended March 31, the pharma company posted a 105 per cent rise in net profit to Rs 46.37 crore compared with Rs 22.60 crore on a 10 per cent increase in total income to Rs 353.97 crore (Rs 321.78 crore).
For FY03, the firm posted a 50.5 per cent rise in profit at Rs 103.14 crore (Rs 68.51 crore). on a 15.4 per cent increase in total income to Rs 1,214.43 crore (Rs 1,052.40 crore).
